Jazz Pharmaceuticals (JAZZ) Refocuses Its Sleep Franchise, Is The Stock Still Cheap?

Jazz Pharmaceuticals (JAZZ) is back in focus after Axsome Therapeutics disclosed an FDA filing for AXS-12 in narcolepsy, ...
FiercePharma

Jazz's Xywav scores the first FDA nod in idiopathic hypersomnia, and big sales could follow

Those who have the sleep disorder idiopathic hypersomnia finally have relief. But it comes in the form of a medicine with tight regulations and safety concerns. On Thursday, Jazz Pharmaceuticals ...